- Home
- TPST vs MERC Comparison
TPST vs MERC Comparison
Compare TPST & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TPST | MERC |
|---|---|---|
| Founded | 2011 | 1968 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7M | 16.0M |
| IPO Year | 2012 | 2005 |
Fundamental Metrics
Financial Performance| Metric | TPST | MERC |
|---|---|---|
| Price | $0.53 | $0.14 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $0.38 |
| AVG Volume (30 Days) | 306.6K | ★ 677.8K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $295,000.00 | ★ $1,169,145,000.00 |
| Revenue This Year | N/A | $4.82 |
| Revenue Next Year | N/A | $10.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 25.50 |
| 52 Week Low | $0.52 | $0.16 |
| 52 Week High | $11.13 | $2.85 |
Technical Indicators
Market Signals| Indicator | TPST | MERC |
|---|---|---|
| Relative Strength Index (RSI) | 27.88 | 23.69 |
| Support Level | N/A | N/A |
| Resistance Level | $1.24 | $0.41 |
| Average True Range (ATR) | 0.05 | 0.03 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 2.69 | 3.54 |
Price Performance
Historical ComparisonAbout TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets. Company's small-molecule product candidate, amezalpat (previously known as TPST-1120), has completed a Phase 2 study in first-line hepatocellular carcinoma and the second small-molecule product candidate is TPST-1495, plans to initiate a Phase 2 study for in familial adenomatous polyposis.
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the maximum of revenue is generated from the China. The majority of the revenue is generated from the Pulp segment.